Antimicrobial resistance mechanisms, treatment challenges, and emerging strategies in Stenotrophomonas maltophilia infections
Abstract
Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen widely distributed in natural and clinical environments, and has increasingly been recognized as a significant cause of nosocomial infections. Owing to its complex intrinsic resistance mechanisms and the continuous evolution of acquired resistance, the clinical management of S. maltophilia infections remains highly challenging. Resistance in S. maltophilia is mediated by multiple mechanisms, including chromosomally encoded L1/L2 β-lactamases, multidrug efflux pump systems, reduced outer membrane permeability, and biofilm formation, as well as the acquisition of resistance determinants via mobile genetic elements. In addition, virulence-associated traits, including quorum sensing systems, and extracellular enzyme production, contribute to host adaptation and persistent infection. Trimethoprim–sulfamethoxazole (TMP–SMX) remains the first-line therapy. However, increasing resistance has been reported in certain regions. Alternative and combination therapies, including minocycline and fluoroquinolones, are increasingly utilized. Meanwhile, emerging strategies such as efflux pump inhibitors, anti-virulence approaches, and bacteriophage therapy have attracted growing attention. This review provides a comprehensive overview of the resistance mechanisms, virulence-associated phenotypes, and current therapeutic advances of S. maltophilia , with particular emphasis on resistance evolution and novel treatment…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.